Delivery Order SPE2DB24D1201-SPE2DB25FJDNC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,205.52 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $13,124.59 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on April 24, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,304.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order valued at $13,408.48 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages) on September 23, 2025, with completion scheduled for September 24, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,373.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,875.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This contract was competitively awarded without set-aside designation and is structured as a firm fixed price delivery order, with an ultimate completion date of August 1, 2025. The award was issued on July 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $37,329.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 4, 2025, with completion targeted for September 5, 2025. This non-competed, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDNCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,236.48 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside award is structured as a firm fixed price delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp serves as a prime pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio of federal contracts encompasses a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for NURTEC ODT, a migraine treatment medication, reflects AmerisourceBergen's ongoing role in supplying essential medications to support Defense Health Agency and other government healthcare system needs through the flexible and comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 7/18/25 |